Our Research Priorities
Drive Strategic Investments
March 14, 2019
Patients, physicians, researchers and industry convened at a conference in Denver to discuss the benefits and risks of medical marijuana for people with PD.
March 11, 2019
A new study suggests urate may protect the genetic mutation that increases PD risk.
UPCOMING FUNDING PROGRAM DEADLINES
Deadline: Pre-Proposals Due: April 19, 2019, 5 p.m. ET
Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program supports projects with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care.
Deadline: Pre-Proposals Due: CLOSED
Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.